Lifecare ASA

AGM Information • May 16, 2024

Minutes from Extraordinary General Meeting

Minutes from Extraordinary General Meeting

The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid

meeting on 16 May 2024.

All proposals on the agenda were adopted, cf. the notification of the

Extraordinary General Meeting that was published on Oslo Stock Exchange on 2.

May 2024. The complete minutes of the Extraordinary General Meeting are

attached and will be available on https://lifecare.no/investor-relations/

About us

Lifecare ASA is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare ASA, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,

asle.wingsternes@lifecare.no, +47 41 61 42 52

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication at

2024-05-16 13:25 CEST.